CYP2D6 and HOXB13/IL17BR: Combining inherited and tumor gene markers for prediction of tamoxifen resistance
- Citation:
- Clin Cancer Res vol 14 (18) 5864-5868
- Year:
- 2008
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- 664
- Children:
- None
- Pharmas:
- Grants:
- P30 CA015083-240001, CA116201, U-01 GM61388, R01 CA087898-01A2, CA 90628, R01 CA087898, U10 CA025224-28, K12 CA090628, CA-25224, U01 GM061388, K12 CA090628-05, U01 GM061388-07, P50 CA116201, P30 CA015083, P50 CA116201-01, U10 CA025224, CA 15083, N01 CA015083, CA87898
- Corr. Author:
- Authors:
- Matthew P. Goetz Vera J. Suman Fergus J. Couch Matthew M. Ames James M. Rae Mark G. Erlander Xiao-Jun Ma Dennis C. Sgroi Carol A. Reynolds Wilma L. Lingle Richard M. Weinshilboum David A. Flockhart Zeruesenay Desta Edith A. Perez James N. Ingle
- Networks:
- Study
- NCCTG-89-30-52
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Tamoxifen, Cytochrome P450 2D6, HOXB13/IL17BR, Breast cancer